Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies

SA Cherrak, H Merzouk, N Mokhtari-Soulimane - Plos one, 2020 - journals.plos.org
A novel coronavirus responsible of acute respiratory infection closely related to SARS-CoV
has recently emerged. So far there is no consensus for drug treatment to stop the spread of …

In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2

S Garg, A Roy - Chemico-Biological Interactions, 2020 - Elsevier
In the present situation, COVID-19 has become the global health concern due to its high
contagious nature. It initially appeared in December 2019 in Wuhan, China and now …

Molecular modeling of isolated phytochemicals from Ocimum sanctum towards exploring potential inhibitors of SARS coronavirus main protease and papain-like …

KK Varshney, M Varshney, B Nath - Available at SSRN 3554371, 2020 - papers.ssrn.com
Background: In December 2019, there was a cluster of pneumonia cases in China.
Investigations found that it was caused by a previously unknown virus, now named the 2019 …

Potential of Plant Bioactive Compounds as SARS‐CoV‐2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study

TE Tallei, SG Tumilaar, NJ Niode, fnm Fatimawali… - …, 2020 - Wiley Online Library
Since the outbreak of the COVID‐19 (coronavirus disease 19) pandemic, researchers have
been trying to investigate several active compounds found in plants that have the potential to …

[HTML][HTML] Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A …

MR Rameshkumar, P Indu, N Arunagirinathan… - Saudi journal of …, 2021 - Elsevier
An outbreak of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has been
recognized as a global health concern. Since, no specific antiviral drug is proven effective …

Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease

F Batool, EU Mughal, K Zia, A Sadiq… - Journal of …, 2022 - Taylor & Francis
The COVID-19 pandemic has claimed more than a million lives worldwide within a short
time span. Due to the unavailability of specific antiviral drugs or vaccine, the infections are …

Rutin as a promising inhibitor of main protease and other protein targets of COVID-19: in silico study

AA Al-Zahrani - Natural Product Communications, 2020 - journals.sagepub.com
The process of investigating a possible cure for coronavirus disease 2019 (COVID-19) in
vitro and in vivo may take a long time. For this reason, several in silico studies were …

[HTML][HTML] Inhibitory effect of eight secondary metabolites from conventional medicinal plants on COVID_19 virus protease by molecular docking analysis

N Mohammadi, N Shaghaghi - 2020 - europepmc.org
Due to the reported high ability of virulence of COVID_19 in recent months, several studies
have been conducted to discover and introduce COVID_19 antiviral drugs. The results of …

In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2

M Rudrapal, AR Issahaku, C Agoni… - Journal of …, 2022 - Taylor & Francis
Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19,
the development of potent antiviral drug candidates/therapeutic molecules against COVID …

Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – Withania somnifera (Ashwagandha), Tinospora cordifolia …

P Shree, P Mishra, C Selvaraj, SK Singh… - Journal of …, 2022 - Taylor & Francis
Abstract COVID-19 (Coronavirus disease 2019) is a transmissible disease initiated and
propagated through a new virus strain SARS-CoV-2 (Severe Acute Respiratory Syndrome …